Danaher’s point-of-care focused HemoCue subsidiary has launched its newest hemoglobin test in the U.S. following a recent 510(k) clearance from the FDA. The company’s Hb 801 system allows healthcare ...
Although a number of desktop systems allow clinicians to measure urinary albumin excretion directly at the point of care, it is not clear whether these devices are as precise and accurate as central ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback